Search results
Colon cancer is becoming more common in pregnancy: 2 women recall signs that doctors dismissed
TODAY via Yahoo News· 6 days agoAs more young people get colorectal cancer, it's more common in pregnant people. Bleeding, stomach...
Neuroendocrine pancreatic cancer: An overview
Medical News Today· 6 days agoLearn about the symptoms and causes of pancreatic neuroendocrine tumors. This article also discusses diagnosis, treatment options, and more.
Chad Daybell is accused of killing a mother of five. Her children took the stand in his defense
The Independent via Yahoo News· 23 minutes agoTwo of Chad and Tammy Daybell’s adult children testified that their mother’s health had been...
MDs Reveal the Top 2 Stomach Ulcer Causes (Stress Isn't One of Them) + How to Block a Flare-Up
Woman's World via Yahoo News· 2 days agoBleich. “Others can experience indigestion, including symptoms such as bloating, belching and...
Systemic juvenile arthritis: Symptoms, health effects, and more
Medical News Today· 2 days agoSystemic juvenile idiopathic arthritis (SJIA), or “Still’s disease,” is a rare autoinflammatory...
Tick season has arrived with a vengeance. Protect yourself with these tips
Winston-Salem Journal· 2 days agoTick season is kicking into high gear across the U.S. Here’s how you can protect yourself from the...
Beeturia: When Beets Turn Urine Pink to Red
Verywell Health via Yahoo News· 4 days agoWhat Else Could...also thought (based on another older study) that as many as 45% of people who have pernicious anemia will experience red urine after...
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE...
FOX 5 San Diego· 5 days agoAmgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with extensive-stage ...
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved...
WTRF Wheeling· 11 hours agoIn Eli Lilly and Company's (NYSE: LLY) pivotal Phase 3 VIVID-1 study, patients with moderately to severely active Crohn's disease, with or without previous biologic failure ...
Intravenous Immunoglobulin (IVIG) Therapy: How It Works and What to Expect
Verywell Health via Yahoo News· 9 hours agoIntravenous Immunoglobulin (IVIG) therapy is a biologic treatment used for immunodeficiencies,...
